Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists and is a GIP. By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, Tirzepatide has been associated with significant weight loss in clinical trials.  
What’s Included:
Includes
Telehealth Visit (included), Tirzepatide
| Sunday | 3pm - 6pm | 
|---|---|
| Monday | 11am - 9pm | 
| Tuesday | 10am - 7pm | 
| Wednesday | 10am - 6pm | 
| Thursday | Closed | 
| Friday | 4pm - 7pm | 
| Saturday | 10am - 6pm | 
Drop Us a Line